Warfarin use in cancer-associated thrombosis tied to improved overall survival: Study MD Editorial Team29 Sept 2021 9:00 AM ISTUSA: A recent study reported warfarin use to be associated with improved overall survival (OS) versus low-molecular-weight (LMWH) in the treatment of...
Apixaban linked to lesser adverse events in AF elderly patients with frailty: Study Medha Baranwal21 July 2021 9:30 AM ISTUSA: Apixaban compared with warfarin is associated with a lower rate of adverse events across all frailty levels in older adults with atrial...
DOACs associated with lower mortality in comparison to Warfarin, Finds study Dr. Nandita Mohan29 Jun 2021 9:30 AM ISTAmong US nursing home residents, the direct-acting oral anticoagulants (DOACs) were each associated with lower mortality versus warfarin, according...
DOACs Better than Warfarin in Patients with Valvular Atrial Fibrillation, finds study MD Bureau31 March 2021 9:26 AM ISTAtrial fibrillation (AF) affects 5.2 million Americans, results in 158 000 deaths annually, and increases the risk for stroke. Although warfarin has...
Rivaroxaban as good as warfarin in AF patients with bioprosthetic mitral valves: RIVER trial Dr Satabdi Saha17 Nov 2020 3:00 PM ISTResearchers have found in The RIVER trial, the largest study that anticoagulant rivaroxaban worked as well as the standard anticoagulant medication...
DOACs May Confer Lower Fracture Risk Than Warfarin in Afib, confirms study Dr. Kamal Kant Kohli19 May 2020 4:21 PM ISTDirect oral anticoagulants (DOACs) are associated with lower fracture risk than warfarin in patients with atrial fibrillation (AF) finds a new...
Apixaban linked to lower bleeding risk, death compared to warfarin Dr. Kamal Kant Kohli23 Feb 2020 12:00 PM ISTLOS ANGELES -- Researchers have confirmed in a secondary analysis that treatment with the blood thinner apixaban was associated with a lower risk of...
New blood thinner antidote to help doctors move past warfarin savita thakur thakur25 Dec 2015 11:26 PM ISTBy Bill BerkrotNew York: A new class of blood thinners that competes with widely used warfarin should get a boost next year when an "antidote" that...
